comparemela.com

Latest Breaking News On - Artificial immune modulation - Page 1 : comparemela.com

Head to Head Comparison: Spyre Therapeutics (NASDAQ:SYRE) & NexImmune (NASDAQ:NEXI)

NexImmune (NASDAQ:NEXI – Get Free Report) and Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Insider and Institutional Ownership 9.9% of NexImmune shares […]

United statesNeximmune incAeglea biotherapeutics incSpyre therapeutics incGet free reportSpyre therapeuticsSpyre therapeuticGiven spyre therapeuticArtificial immune modulationNeximmune dailyNasdaq nexiStock comparisonStock analysis

NexImmune Announces Closing of $3 67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GAITHERSBURG, Md., Feb. 06, 2024 NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function.

New yorkUnited statesExchange commissionHc wainwright coNeximmune incSecurities actArtificial immune modulationPrivate securities litigation reform actAnnual report

NexImmune Announces Closing of $3 67 Million Registered

NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules.

United statesNew yorkNeximmune incHc wainwright coExchange commissionSecurities actArtificial immune modulationPrivate securities litigation reform actAnnual reportNasdaq nexi

NexImmune Announces Closing of $3 67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

NexImmune Announces Closing of $3 67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkHc wainwright coExchange commissionNeximmune incImmune announces closingSecurities actArtificial immune modulationPrivate securities litigation reform actAnnual report

NexImmune Announces Closing of $3 67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

NexImmune Announces Closing of $3 67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkExchange commissionNeximmune incHc wainwright coSecurities actArtificial immune modulationPrivate securities litigation reform actAnnual report

vimarsana © 2020. All Rights Reserved.